Recent News
Powered by Alpha Vantage
No recent news found.
AI Tools
Key Metrics
Trend: Downtrend
Source: Snapshot
Incannex Healthcare Limited is engaged in the research, development and sale of medicinal cannabinoid products in Australia. The company is headquartered in Sydney, Australia.
52W High
$3.12
52W Low
$0.08
MA Status:
50D: Below
200D: Below
Beta (~1 neutral, <0.9 lower risk)
2.71
Valuation
As of 2025-03-31 (Overview)
Trailing P/E (<15 better)
N/A
Forward P/E (<15 better)
N/A
EV/EBITDA (<8 favorable)
-5.13
EV/Revenue (<3 favorable)
450.67
P/S (TTM) (<3 favorable)
501.94
P/B (<3 favorable)
6.64
Ownership
Retail‑heavySource: Overview
Insiders (1–5% typical)
26.14%
Institutions (25–75% balanced)
10.42%
Shares Outstanding
93,695,000
Float
28,234,100
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
Profitability: Weak
As of 2025-03-31 (Overview)
Revenue (TTM)
98,000
Gross Profit (TTM)
98,000
EPS (TTM)
-1.23
Profit Margin (>10% good)
N/A
Operating Margin (TTM) (higher better)
-209.52%
ROE (TTM) (>15% strong)
-2.02%
EPS YoY (Quarterly) (>10% good)
N/A
Revenue YoY (Quarterly) (>8% good)
0.30
Momentum
Bearish momentumValue
0.0047
Previous
0.0068
Trend
Falling
Signal Cross
No cross
As of
Sep. 12, 2025